Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Man what a deal! Not worth cashing in my millions of shares here tho :)
Will wait for the story here to unfold and then by much much more gold.
More consolidation here! Another almost 60k shares sucked up into stronger hands.
Good to see cause when news comes out, there will be less friction!
If that's your best shake attempt then you better SLAP THAT ASK, cause you're not gonna shake a leaf loose with that spewage.
Yessir, that seller must be sick right now! All that dumpage thinking they would get the dividend shares... NOPE... and now they have nothing left now for the REAL run!
But too bad for them and very good for us!
We've got some nice, steady accumulation here! This past week has seen most days well in excess of the 3 month average.
Next step will be UP from here!
Oh good choice! Both are gonna be HUGE!
Too late? Never too late. I do own shares, but not a ton.
Fill me in why that makes you nervous please?
Flow chart had it listed as Bayport NOLA.
*EDIT* Just googled my business with some of these "professional" valuations and its WAY off. Completely wrong.
It's the ACT of trading on the knowledge that is illegal, not the posession of the knowledge.
Now can we please move on to something more pertinant?
Hi everyone,
I'm new to this board, and have not dabbled in BioTechs much, but I've seen what can be gained from a successful run.
Part of the reason I'm here is that I've sorta stumbled over a possible runner, and all things I've seen point to it being successful, but would like to see what you all think.
The Ticker is: PROT Proteonomix, Inc
SS is: 6,735,556 O/S 4,431,155 Float, verified by me direct from the T/A 2 days ago.
Here is a recap from an Investors Info sheet from the company.
Good volume... someone is picking up some good priced shares here!
;P
Good luck here! Ms Gutierrez earned herself my respect today.
Thank you for clearing this up Stervc! I hope this makes some people here more optimistic.
I've been burned before, and I no longer trust those that burned me, so I can understand their pain. However,in this case, I think they have mistaken who it was that burned them...
Proteonomix is a public biotechnology corporation. We have developed a range of stem cell related technologies in cooperation with John’s Hopkins University and the University of Miami.
We are immediately ready to enter phased human trials on two medical treatments and to launch a line of anti-aging cosmeceuticals based upon these technologies.
Proteoderm: A line of Anti-Aging products based upon a matrix of proteins secreted from
our stem cell growth platform that stimulates collagen formation.
UMK 125: A treatment for liver disease and other possible applications using a
combination of two approved drugs to mobilize particular bone marrow stem cells.
StromaCel: A treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bon marrow and administered via IV solution.
The company is now seeking funding. Initial use of funding will be to perform human trials for UMK 125, scheduled for start in Q3 2011 with U Miami and to launch Proteoderm through a physician network. We further intend to begin treating patients with StromaCel in medical tourism destinations, such as the Dominican Republic where we have several facilities under contract.
Sure it does. Board of Directors tells the Porters that they are going to do a Reverse Split. Porters argue, BoD still says yes, Porters stop the R/M and walk away.
BoD does R/S anyways, and is still searching for another candidate for a Merger.
Just because it was completed after the R/M failed does not mean it wasn't planned before.
I think what annoyed the Porters is that BYSD did the Reverse Split, aiming to dump shares.
Either way, sorry for those in BYSD, but this is EXTO and the Porters have control here now.
Exit Only, Inc. (PINKSHEETS: EXTO) today announced that it has acquired Bayport Corporation, a Nevada corporation. With this acquisition, Bayport Corporation has obtained the controlling interest in the company.
Has, to me, is a PAST looking statement. Controlling interest was in the form of 2m Preferred shares with 1:1 conversion and 1000:1 voting rights.
There have been no new shares created, common or preferred. Please feel free to call them yourself.
Ok, lets use logic here.
Monday's press release states that the transfer is complete.
I called the Transfer Agent today and guess what? Share structure is exactly the same as it was 2 weeks ago. If there was to be payment using EXTO shares, then they'd already be issued.
Why don't you do the same? Call the company and ask? Call the T/A and ask! All I'm saying is asking for this information on an anonymous chat board is not the correct way to do DD.
I'm sure you can see that as very rational.
What does it matter what the terms are? If you're concerned with Share Structure, CALL THE T/A. If you want to know the terms CALL THE COMPANY.
Posting this dribble on an anonymous message board will not get you the right answer. Even if someone replies you can't take it for fact.
Personally I could care less what they paid for the shell after talking to Mr Porter today.
I'm a long been here for many moons. Not going anywhere, not selling any till I know what I have.
Peace out, seems like you don't want to party here with us. That's your choice.
I wish you luck on whatever you choose to do.
*EDIT AS IM OUT OF POSTS FOR THE DAY*
Petro, some things happened between the Porters and BYSDD. What I can tell you is this:
1. Porters did NOT do the Reverse split there and hose all the shareholders.
2. Porters did NOT attack the Board of Directors in a PUBLIC FILING calling them criminals.
3. Porters DID walk away due to some altercation that we will never ever know the full story.
If you have a grudge VS BYSDD, nobody can blame you. But to take out out here is uncalled for. Stervc was one of those impacted in the BYSDD R/S, and he's calling for this to be a big play. I know him, I trust him, I'm listening to him.
Good night, this is the last I reply to you so please follow suit.
Apparently they are.
Ok.. Reverse Merger 101 in Play form.
(ACT 1)
"Hi EXTO Management, we're Bayport, we want to buy your publicly traded shell."
"Hi Bayport, we're EXTO Management, we'll gladly sell that to you."
"Thank you EXTO, here's payment."
"You're welcome Bayport, here are the keys."
*EXTO Management exits stage left, never to be seen again*
*Bayport puts keys in door and conducts business*
(AUDIENCE STANDS AND CLAPS LOUDLY)
In other words, if you sell your house to someone, you do NOT get to come back and hang out in the living room.
Nice volume here! 46k shares at 50 cents. And a small green close.
I'm thinking we see dollars here VERY soon!
Yes please do not mention They-Who-Shall-Not-Be-Named!
Thats like saying Betelgeuse 3 times... Nothing good can ever come of it!
That is an amazing array of businesses and the CEO says they're all profitable??
I'm lovin' it!
Stellar DD! Stervc you outdid yourself again!
All I can say is that I'm pretty good at being able to read people, and I have no doubt that this man is 100% legit.
Please call him. 702-629-6312.
Eek you here too? Hahahahahahaha!
So far your tips on these are 100% spot on! Thanks for the heads up here!
Love that other one too... once FDA approval hits BOOM!
Hiya Max!
Just called the Bayport office and spoke to Mr Lou Porter. He was very receptive to inquiries, and was very nice.
I left the conversation thinking this is going to be a very very special ride from here.
I like what I see here. Sounds like the Porters had a plan to bring their companies public a few months ago but it appears to have fallen apart.
The PR Monday states the acquisition is complete! So nothing to fall apart here! Better for those who have held on here.
Stervc has given an estimate using 1% of recoverable ores, a 25% profit margin and industry average of 24.50x P/E ratio. The final number was 51 cents I believe?
This lil beauty could be a lifechanger. I can't wait to see how the story unfolds.
Talk about full declaration. Read their latest Q/K and you can see how the company is lined up.
1. Sperm bank - cryogenics for cord blood (?) etc should the time come.
2. Dominican Republic corporation - HUGE medical tourism there.
3. Proteoderm - apparently there are protein polypeptides and growth hormone secreted by stem cells. How big is the cosmeceutical market? The lotions etc that my wife uses are VERY expensive. I'd think this would be lucrative!
4. StromaCel, Inc. - to develop therapies using stromal cells. Stromal cells are key components of tissues and provide critical cytokines and growth.
5. Proteonomix Regenerative Translational Medicine Institute, (PRTMI) - to focus on the translation of research in stem cell biology and cellular therapy to clinical applications of regenerative medicine.
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=7884310
Proteonomix, Inc. (the “Company") is a Delaware corporation incorporated on June 26, 1995 as Azurel, Ltd. In September 2006, Azurel, Ltd. changed its name to National Stem Cell Holding, Inc. and then in August 2008 the name of the Company was changed to Proteonomix, Inc.
Azurel, Ltd. was incorporated on June 26, 1995 in the State of Delaware and marketed a line of fragrances. On February 2, 2001, Azurel filed a voluntary petition for protection from creditors under Chapter 11 in the United States Bankruptcy Court for the District of New Jersey, Newark until it was discharged from bankruptcy in December, 2005. Control was changed in September 2006 when Azurel acquired National Stem Cell, Inc. and its subsidiary, The Sperm Bank of New York, Inc. through a share exchange agreement. In this transaction the common stock was reverse split 1:37. Azurel subsequently changed its name following the acquisition. Then again in August 2008, the Company reverse split its stock 1:10 when the name was changed to Proteonomix, Inc.
On January 14, 2005, National Stem Cell, Inc. acquired The Sperm Bank of New York, Inc. a company established in 1997 operating as a reproductive cell and tissue bank. National Stem Cell, Inc. acquired The Sperm Bank of New York, from its sole shareholder, for a note payable in the amount of $150,000 and acquired the accounts receivable and inventory valued at $150,000. On January 13, 2006, National Stem Cell Inc. converted the note payable into 21,866 shares of common stock. The acquisition was treated as a purchase transaction.
On July 8, 2008, the Company formed Proteoderm, Inc. as a wholly-owned subsidiary. Through this subsidiary, the Company produces and synthesizes protein polypeptides and growth hormone secreted by stem cells and incorporates them into uniquely formulated personal care products. Proteoderm, Inc. has generated no revenues since inception.
On January 5, 2010, the Company formed the Proteonomix Regenerative Translational Medicine Institute, (“PRTMI”), as a wholly-owned subsidiary. PRTMI will focus on the translation of research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. PRTMI formed PRTMI RD, a company incorporated in the Dominican Republic in February, 2010.
On February 24, 2010 the Company acquired StromaCel, Inc., a wholly-owned subsidiary for the price of its formation cost on December 24, 2009. The mission of StromaCel is to develop therapies using stromal cells. Stromal cells are key components of tissues and provide critical cytokines and growth factors as well as the cellular microenvironment for normal homeostasis.
On May 4, 2010, Proteonomix licensed from the Cohen-McNiece Foundation the Stromal Cell technology for potential therapeutic use in the regrowth of damaged cardiac cells after a heart attack. The Cohen-McNiece Foundation was formed by Proteonomix President, Michael Cohen, and its Chief Scientific Officer and Vice-President, Ian McNiece, PhD to develop cellular technology for patients who have suffered myocardial infarctions.
The Technology was licensed in exchange for a 2% royalty on gross revenue derived from use of the StromalCel Technology and 1,000,000 stock options exercisable for five years at $3.55 per share vested immediately to Michael Cohen, our President and 90% owner of the Cohen-McNiece Foundation. The 2% royalty will be used by the Foundation to do further research into stem cell applications. Proteonomix also received a right of first refusal to license any technology developed by the Foundation.
Proteonomix has sub-licensed the StromaCel Technology to StromaCel for a 2% royalty, but Proteonomix will remain responsible for all costs associated with patent prosecution for the StromaCel Technology. In the event of bankruptcy, the rights to the Technology granted by the license revert to the Foundation.
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=7853324
Proteonomix, Inc. (PROT) Files New Patent Application for a New Technology to Focus on Mobilization of Bone Marrow Stem Cells and Begins to Prepare for a Clinical Trial Based on the Patent Application
MOUNTAINSIDE, NJ--(Marketwire - April 7, 2011) - PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it has filed a provisional patent application in anticipation of commencement of its initial clinical trial of a drug combination thought to extend life expectancy for a class of terminally ill patients awaiting liver transplants.
Based upon our previously announced exclusive license agreement to develop Mobilization of Bone Marrow Stem Cells Technology (UMK-121), the Company has filed a patent application covering mobilization of non-hematopoietic stem cells for applications in regenerative medicine.
Planning for the first clinical trial has been initiated and we expect to commence the trial in 2011. If successful, such a trial will be a critical step toward proving the efficacy of the technology upon which the application was filed and key to further development of the company's portfolio of stem cell treatments.
Ian McNiece, Chief Scientific Officer of Proteonomix, noted, "The filing of this patent application strengthens the intellectual portfolio of the company and paves the way forward for initiation of phase I trials of this technology. We believe this mobilization technology has extensive potential to facilitate cellular repair in a number of diseases and will be key focus for Proteonomix moving forward."
Michael Cohen, Proteonomix, Inc. CEO, stated: "We are methodically developing this new technology. Our initial targeted patients for this new therapy will be those who are suffering from End Stage Liver Disease ("ESLD"). We are currently seeking to partner with a medical facility to assist us with the future growth of this technology."
Spoke to the T/A today and the pertinant numbers are:
OS - 6,735,556
Float - 4,431,155
Hey Playstay! Thanks for the 411 on this one. Took a good position in it yesterday and today. Did some DD and this is looking VERY VERY good.
Will share on a separate post.
Giovanni should have signed with just his name then.... Giovanni Luciano. Why did he sign on May 31, 2011 with a title if he didn't have a title on May 31?
He resigned on May 2 according to the Q1. Nothing says they are transferred... just issued.
These Preferred Share certs are signed by Giovanni Luciano and Calvin Ross and they both have titles listed under their names. Chief Operations Officer and Chief Financial Officer... dated May 31, 2011. Why did the company say Giovanni Luciano resigned May 2, 2011 in the Q1 filings if he's still signing his name on May 31, 2011 as COO?
Here is the blurb in the Q1 filing stating this...
Subsequent Events
On May 2, 2011, Giovanni Luciano resigned as COO and Director of Hall of Fame Beverages Inc
Now here is a link to the certs signed on May 31, 2011 by Giovanni Luciano and listed as Chief Operations Officer:
http://www.halloffamebeverages.com/investor_relations
Now, quite honestly if you know this company's history of lies and faking events, and you're the question asking type of shareholder, then this post is for you. I say who cares if they issued preferred shares to Brad and to JAG it is just for appearances because they need you to believe Calvin and Giovanni are gone. So, everyone involved (Calvin, Giovanni, LJ, Jessica (LJ's publicist), Brad) is willing to play this "song and dance" to convince the base that needs it all to be real... that it is real or at least looks different than before so it must be real. You notice everyone is still related to all the lies from before? Calvin and Giovanni and LJ have been running this scam for years... Jessica is LJ's publicist... and Brad is gullible shareholder and long time insider who has put more money in all of their pockets, than anyone.
All the players in this song and dance say... If it will accomplish that end goal, then so be it "transfer the shares." After all no one will ever see behind closed doors, so no one will know who is doing what, but with Larry Johnson being named a part of JAG, I think that sealed it that the 3-amigos (Calvin, Giovanni and LJ) are still in cahoots, but for appearances sake they had to give it a little different look. It doesn't matter how many times they say Calvin and Giovanni are gone, or how many documents they show that state that Calvin and Giovanni are gone... they aren't gone.
We don't know what the details were behind closed doors. As far as we all know, Calvin and Giovanni just issued Brad and JAG (LJ) preferred shares from the 30,000,000 Preferred AS... I don't see any paperwork or details stating Calvin and Giovanni gave up their own preferreds or the details behind that transaction. But, if they did, who cares because the devil is in the details... what was the agreement behind closed doors... that is what matters and no document or statement matters. It's all for appearances.
Anyone can say they are leaving if everyone hates them being there (Calvin & Giovanni), and then just turn over their power to their "best friend" (LJ). The "best friend" (LJ) for God's sake has been in on it for years with them, so he'll just be the name on the documents while his best friends (Calvin & Giovanni) are still setting up everything business as usual.
You may have the base that asks no questions fooled, but the rest of the Market is wise to the HFBG game!
Ok lets try this one last time. On December 31, 2010, according to the Year End report, the float was 59m and some change.
These 26m shares were issued in 2011.
Last friday, they updated Pinksheets and stated that the float was STILL 59m and some change. So these shares are either:
A. Restricted
or
B. Already accounted for in the Public Float.
So they are a non-issue.
STANDS AND CLAPS! People choose to be argumentative when they do not like what is presented.
12/31/2010 through 6/10/2011 the float is UNCHANGED. Thats what I care about.
The answer to that lies in the other reports then doesnt it? Flip to the Year End 12/31/2010 Annual report... What is the float there?
Ok now go to the filing this past Friday... What is the float there?
Soooo... you tell me. Those shares restricted or free trading?
Reg 144 as announced in Friday's report. I'm saying that the FLOAT will not grow any larger than it is anytime soon.
Explain it "NOW???" Wow...
Ok I'll explain this once again. In crayon this time so you all can understand.
144 Restricted Rules for a FULLY REPORTING COMPANY is a minimum 6 month waiting period for the shares to be deposited for resale. This is at the time of the share issuance.
Sooooo
Was SHAR fully reporting back in November when they issued restricted shares? Nope.
Therefore, 12 month Restricted Period.